AngioDynamics, Inc.

Radiofrequency Ablation Yields High Proportions of Sustained Complete Responses in Patients with Lung Cancer

Published in Medical Devices and Surgical Technology Week, August 3rd, 2008

AngioDynamics (NASDAQ:ANGO) announced results from its RAPTURE study, which was conducted to identify the feasibility, efficacy and safety of percutaneous radiofrequency ablation (RFA) of malignant lung tumors. Published in The Lancet Oncology July 2008 issue, the results show a high proportion of sustained, complete tumor response after treatment with RFA.

This prospective, intention-to-treat clinical trial enrolled 106 patients with 183 lung tumors that were 3.5 cm in diameter or smaller (mean 1.7 cm) at seven centers in the United States, Europe, and Australia. Diagnoses included non-small-cell lung cancer (NSCLC) in 33 patients, metastasis from colorectal carcinoma...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2008-08-03)

More Articles from Medical Devices and Surgical Technology Week

American Society for Therapeutic Radiology and Oncology
Treating rare breast cancer with radiation therapy may lower recurrence rate
Tufts University
Tufts researchers discover link between DNA palindromes and disease
Atrial Flutter
Cryoablation Proven Just as Effective as Radiofrequency in the Treatment of Atrial Flutter
Cancer
AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test
Heart Failure
New heart failure study findings have been reported by H. Milting and colleagues
Surgery
Largest Review of Office-Based Plastic Surgery Confirms Safety in Accredited Facilities
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry